FDA announced a direct final rule updating nonclinical testing terminology to remove references to animal testing and to recognize alternative methods. The change reflects an ethics-related shift in biomedical research governance by formally accommodating newer testing approaches within FDA regulations. It also signals continued federal support for methods intended to reduce reliance on animals in preclinical research.
